Citigroup »

Bright Minds Biosciences shares owned by Citigroup

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $22k 297 72.64
2025-03-31 $36 1 36.00
2024-12-31 $36 1 36.00

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences